A new deep learning model combining dermoscopic images with patient metadata achieves 94.5% accuracy in melanoma detection.
Key Details
- 1AI model integrates dermoscopic images and patient data (age, gender, lesion site) for diagnosis.
- 2Achieved 94.5% accuracy and an F1-score of 0.94 using the SIIM-ISIC dataset of over 33,000 images.
- 3Outperformed popular image-only AI models like ResNet-50 and EfficientNet.
- 4Feature analysis showed lesion size, age, and site significantly impact diagnostic accuracy.
- 5Model developed by international team led by Incheon National University; to be published in Information Fusion (Dec 2025).
- 6Potential applications include smartphone-based diagnosis, telemedicine, and AI-assisted dermatology clinics.
Why It Matters
This study demonstrates the value of multimodal AI in diagnostic imaging, highlighting better performance and transparency in early skin cancer detection. Such advances can inform future imaging-AI integration strategies, with implications for clinical workflow and patient care in dermatology and radiology.
Source
EurekAlert
Related News
•EurekAlert
NIH-Backed AI Model Predicts Cancer Survival Using Single-Cell Data
Researchers have developed scSurvival, a machine learning tool that uses single-cell tumor data to accurately predict cancer patient survival and identify high-risk cell populations.
•EurekAlert
Deep Learning Pathomics Platform Improves Immunotherapy Prediction in Lung Cancer
A deep learning pathomics platform accurately predicts immunotherapy response in metastatic NSCLC using routine pathology slides.
•EurekAlert
AI Pathology Model Outperforms PD-L1 in Predicting NSCLC Immunotherapy Response
MD Anderson's Path-IO machine learning platform accurately predicts immunotherapy responses in metastatic non-small cell lung cancer, surpassing current biomarker standards.